Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Liabilities and Shareholders Equity (2020 - 2025)

Intelligent Bio Solutions has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $13.8 million for Q2 2024.

  • For Q2 2024, Liabilities and Shareholders Equity rose 33.07% year-over-year to $13.8 million; the TTM value through Jun 2024 reached $48.3 million, down 1.8%, while the annual FY2024 figure was $13.8 million, 33.07% up from the prior year.
  • Liabilities and Shareholders Equity for Q2 2024 was $13.8 million at Intelligent Bio Solutions, down from $17.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $21.9 million in Q2 2021 and troughed at $2.5 million in Q2 2020.
  • A 5-year average of $13.8 million and a median of $14.1 million in 2022 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 782.98% in 2021 and later tumbled 51.09% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $20.0 million in 2020, then decreased by 23.69% to $15.2 million in 2021, then increased by 18.46% to $18.0 million in 2022, then tumbled by 51.09% to $8.8 million in 2023, then skyrocketed by 56.1% to $13.8 million in 2024.
  • Business Quant data shows Liabilities and Shareholders Equity for INBS at $13.8 million in Q2 2024, $17.0 million in Q1 2024, and $8.8 million in Q4 2023.